Skip to main content
2024 Canadian Cardiovascular Congress Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Handout
Handout
Networking
Networking
On-Demand
On-Demand
Early Career Involvement
Early Career Involvement
Back

Michael J. Diamant, MSc, MD, FRCPC (he/him/his)

Clinical Assistant Professor, University of British Columbia
CHFS
University of British Columbia

Michael Diamant is a cardiologist working in Advanced Heart Failure and General Cardiology, and acts as the Heart Function Clinic Physician Co-Lead, at Royal Columbian Hospital. He is also a Clinical Assistant Professor in the Faculty of Medicine at the University of British Columbia (UBC). He holds a Master’s of Science in Epidemiology from the University of Western Ontario, completed Cardiology residency at UBC, and went on to complete a fellowship in Advanced Heart Failure and Transplant at Vanderbilt University Medical Center in Nashville, Tennessee. Michael sits on multiple provincial and regional committees that direct and advise on management, quality of care, treatment coverage, and remote monitoring for patients with heart failure and cardiac amyloidosis. His research interests include outcomes in health services delivery in heart failure, donor organ availability, and as a site investigator in heart failure drug and intervention trials. He also plays an active role in teaching in UBC’s medical school and cardiology residency program, including as the Heart Failure and Valvular Disease Week (Week 59) curriculum lead for undergraduate medical education, and serves on the Education Committee for the Canadian Heart Failure Society.

Disclosure(s): Astra Zeneca: Principal site investigator in BalanceD Trial (Ongoing); Bayer: Advisory board member regarding vericiguat (Terminated, May 2, 2024), Site sub-investigator for FINEARTS HF Trial (Terminated, May 2, 2024); Medtronic: HF Site Investigator for APOLLO Trial (Ongoing); Pfizer: Advisory board regarding amyloidosis care (Ongoing), Principal site investigator in clinical trial (GARDEN-TIMI Trial) (Ongoing), Speaker honoraria (Ongoing)

Presentation(s):